WO1984001710A1 - Cosmetic preparation - Google Patents
Cosmetic preparation Download PDFInfo
- Publication number
- WO1984001710A1 WO1984001710A1 PCT/US1983/001679 US8301679W WO8401710A1 WO 1984001710 A1 WO1984001710 A1 WO 1984001710A1 US 8301679 W US8301679 W US 8301679W WO 8401710 A1 WO8401710 A1 WO 8401710A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- cosmetic
- cosmetic preparation
- accordance
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to cosmetic preparations and in particular to cremes, lotions and liquids for moisturizing the skin.
- emolients and surface active agents have been incorporated in the emulsions, including stearates, such as potassium stearate, glycol stearate, sodium stearate, PEG 40 stearate and glyceryl stearate; laurates, such as sodium laurate and potassium laurate; alcohols, such as cetyl alcohol and lanolin alcohol; triethanolamine; myristates, such as isopropyl myristate, sodium myristate andpotassium myristate; cetyl palmitate; cholesterol; stearic acid; and sorbitan sesquioleate.
- Stabilizers such as methyl paraben and propyl paraben, are commonly incorporated in the cosmetic preparations.
- a principal object of the present invention is to provide an improved cosmetic preparation of either the liquid or of the emulsion type wherein the improved preparation is most effective in moisturizing the epidermis, softening the skin, improving the texture and feel of the skin and diminishing superficial and deep wrinkles in the skin.
- the above objective is achieved in accordance with the present invention by providing a cosmetic preparation of the creme, lotion, or liquid variety which has incor porated therein from about 0.1% up to about 1% gibberellic acid and frcm about 0% up to 5% lysine.
- the lysine utilized in the preparation is L-lysine which is a natural occurring form of lysine.
- the dextro isomer can be used as well as analog of lysine, such as hydroxy lysine.
- the improved preparation may also contain frcm about 0.01% to 5% gliadin, from about 0.005% to 1% ascorbic acid, from about 0.01% to 5% urea and up to 1% calcium.
- the performance of the liquid water base preparations and the water-oil emulsion type preparation can be substantially and markedly enhanced with respect to moisturizing the epidermis, softening the skin, improving the texture and feel of the skin and in diminishing superficial and deep wrinkles in the skin by incorporating the above mentioned ingredients into the cosmetic preparations.
- Cosmetic preparations can be prepared in accordance with the present invention from numerous cosmetic base ingredients which are well known in prior art.
- Such bases may comprise emulsions containing various emolient ingredients.
- Lanolin or other oils from the group consisting of animal oils, vegetable oils and mineral oils are emulsified with water as is well known in the art.
- other emolients and surface active agents such as those mentioned hereinbefore can be incorporated in the emulsions as is also well known in the art.
- Stabilizers and preservatives can be included within the cosmetic preparation as is also well known in the art.
- the essence of the present invention is not within the composition of the base per se, and any of extremely many base formulations or ccmpcsitions of the water or emulsion type currently used in cosmetic skin preparations can be employed.
- the essence of the present invention is in the incorporation of specific ingredients within the creme, lotion, or liquid preparation which substantially and markedly enhance the performance of the cosmetic preparation in moisturizing the epidermis, softening the skin, improving the texture and feel of the skin and in diminishing superficial and deep wrinkles in the skin.
- the cosmetic preparation comprises a creme, lotion or liquid base which has incorporated therein about 0.01% up to about 1% gibberellic acid and from about 0% up to about 5% lysine.
- the improved cosmetic preparation may also contain, in addition to the gibberellic acid and lysine, up to about 5% gliadin, up to about 1% ascorbic acid and up to 5% urea.
- Preferable concentrations of the latter ingredients when used in the cosmetic preparation are from about 0.03% to 1% gliadin, from about 0.01% to 0.05% L-ascorbic acid and from about 0.03% to 1% urea.
- the improved cosmetic preparation may also contain, in addition to the abovementioned ingredients up to about 1% calcium. All percentages given throughout the specification and claims are by weight.
- a specific formulation of a preferred embodiment of a cosmetic creme in accordance with the invention is as follows:
- the women were given a container of creme in accordance with the invention and a container of the creme base of the test product of this invention, i.e., the same creme but lacking the lysine, urea, gliadin, ascorbic acid and the gibberellic acid.
- the only markings on the containers given the women were instructions to apply the creme from the respective containers to one side of their faces with the creme in the other container being applied to the other side of their faces. All subjects were assessed after one month. Almost unanimously, the women reported a substantial improvement in visual appearance of the side of their faces to which the creme of this invention had been applied in comparison to the side to which the commercially available skin cremes and the creme base had been applied.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP84500001A JPS59501986A (en) | 1982-11-04 | 1983-10-28 | cosmetic formulations |
AU23399/84A AU2339984A (en) | 1982-11-04 | 1983-10-28 | Cosmetic preparation |
DK324584A DK324584D0 (en) | 1982-11-04 | 1984-07-02 | COSMETIC PREPARATION |
FI842697A FI842697A (en) | 1982-11-04 | 1984-07-04 | COSMETIC PREPARATION. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43911382A | 1982-11-04 | 1982-11-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1984001710A1 true WO1984001710A1 (en) | 1984-05-10 |
Family
ID=23743346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1983/001679 WO1984001710A1 (en) | 1982-11-04 | 1983-10-28 | Cosmetic preparation |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0126138A1 (en) |
JP (1) | JPS59501986A (en) |
DK (1) | DK324584D0 (en) |
FI (1) | FI842697A (en) |
NO (1) | NO842674L (en) |
WO (1) | WO1984001710A1 (en) |
ZA (1) | ZA838207B (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2608425A1 (en) * | 1986-12-17 | 1988-06-24 | Rofsa Cerd | Cosmetic composition for the selective partial depigmentation of the skin and process for manufacturing it |
WO1992021321A1 (en) * | 1991-05-27 | 1992-12-10 | Laboratoires Inocosm | Method for separating a vegetable compound |
EP0588379A2 (en) * | 1987-07-02 | 1994-03-23 | Cellegy Pharmaceuticals, Inc. | Treatment of wrinkling |
US5580857A (en) * | 1989-12-12 | 1996-12-03 | Oden; Per | Use of gibberellins for the treatment of prostatitis |
US6121317A (en) * | 1995-01-06 | 2000-09-19 | Australian Biomedical Company Pty. Ltd. | Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing |
WO2003094907A1 (en) * | 2002-05-06 | 2003-11-20 | Kimberly-Clark Worldwide, Inc. | Cell proliferating agents |
WO2013091684A1 (en) * | 2011-12-20 | 2013-06-27 | Oriflame Research And Development Ltd. | Compounds with anti-aging activities |
EP2716651A2 (en) * | 2011-05-23 | 2014-04-09 | Incospharm Corporation | Peptide derivatives having a superior moisturizing effect and uses thereof |
US9775908B2 (en) | 2007-07-10 | 2017-10-03 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Pharmaceutical preparations containing highly volatile silicones |
EP3158989A3 (en) * | 2017-02-01 | 2017-10-11 | SanderStrothmann GmbH | Cosmetic skin treatment composition |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB844549A (en) * | 1958-02-07 | 1960-08-17 | Ici Ltd | Stabilised gibberellic acid compositions and their preparation |
GB910004A (en) * | 1960-03-10 | 1962-11-07 | Thomas Jenkins Lewis | Cosmetic skin preparations containing low gel strength, low viscosity gelatin |
GB1228888A (en) * | 1968-10-08 | 1971-04-21 | ||
US3970759A (en) * | 1972-12-11 | 1976-07-20 | Exxon Research And Engineering Company | Aliphatic diols as preservatives for cosmetics and related products |
US4154823A (en) * | 1976-06-10 | 1979-05-15 | Schutt Steven R | Skin treatment compositions and methods of using same |
-
1983
- 1983-10-28 EP EP83903849A patent/EP0126138A1/en not_active Withdrawn
- 1983-10-28 JP JP84500001A patent/JPS59501986A/en active Pending
- 1983-10-28 WO PCT/US1983/001679 patent/WO1984001710A1/en not_active Application Discontinuation
- 1983-11-03 ZA ZA838207A patent/ZA838207B/en unknown
-
1984
- 1984-07-02 NO NO842674A patent/NO842674L/en unknown
- 1984-07-02 DK DK324584A patent/DK324584D0/en not_active Application Discontinuation
- 1984-07-04 FI FI842697A patent/FI842697A/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB844549A (en) * | 1958-02-07 | 1960-08-17 | Ici Ltd | Stabilised gibberellic acid compositions and their preparation |
GB910004A (en) * | 1960-03-10 | 1962-11-07 | Thomas Jenkins Lewis | Cosmetic skin preparations containing low gel strength, low viscosity gelatin |
GB1228888A (en) * | 1968-10-08 | 1971-04-21 | ||
US3970759A (en) * | 1972-12-11 | 1976-07-20 | Exxon Research And Engineering Company | Aliphatic diols as preservatives for cosmetics and related products |
US4154823A (en) * | 1976-06-10 | 1979-05-15 | Schutt Steven R | Skin treatment compositions and methods of using same |
Non-Patent Citations (1)
Title |
---|
The Cosmetic Formulary, issued 11 August 1941, H. BENNETT, see pages 2 to 15, 36 and 37. * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2608425A1 (en) * | 1986-12-17 | 1988-06-24 | Rofsa Cerd | Cosmetic composition for the selective partial depigmentation of the skin and process for manufacturing it |
EP0588379A2 (en) * | 1987-07-02 | 1994-03-23 | Cellegy Pharmaceuticals, Inc. | Treatment of wrinkling |
EP0588379A3 (en) * | 1987-07-02 | 1994-06-01 | Thornfeldt Carl R | Treatment of wrinkling |
US5580857A (en) * | 1989-12-12 | 1996-12-03 | Oden; Per | Use of gibberellins for the treatment of prostatitis |
WO1992021321A1 (en) * | 1991-05-27 | 1992-12-10 | Laboratoires Inocosm | Method for separating a vegetable compound |
US5466782A (en) * | 1991-05-27 | 1995-11-14 | Laboratoires Inocosm | Method for separating a compound containing glycolipids, lysophospholipids, sphingolipids and ceramides of plant origin |
US6121317A (en) * | 1995-01-06 | 2000-09-19 | Australian Biomedical Company Pty. Ltd. | Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing |
WO2003094907A1 (en) * | 2002-05-06 | 2003-11-20 | Kimberly-Clark Worldwide, Inc. | Cell proliferating agents |
US9775908B2 (en) | 2007-07-10 | 2017-10-03 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Pharmaceutical preparations containing highly volatile silicones |
EP2716651A2 (en) * | 2011-05-23 | 2014-04-09 | Incospharm Corporation | Peptide derivatives having a superior moisturizing effect and uses thereof |
EP2716651A4 (en) * | 2011-05-23 | 2014-10-15 | Incospharm Corp | Peptide derivatives having a superior moisturizing effect and uses thereof |
US9359401B2 (en) | 2011-05-23 | 2016-06-07 | Incospharm Corporation | Peptide analogues with an excellent moisturizing effect and use thereof |
WO2013091684A1 (en) * | 2011-12-20 | 2013-06-27 | Oriflame Research And Development Ltd. | Compounds with anti-aging activities |
EA031552B1 (en) * | 2011-12-20 | 2019-01-31 | Орифлейм Ресёрч Энд Девелопмент Лтд. | Non-therapeutic cosmetic topical application of n-acetyl-l-aspartic acid |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
EP3158989A3 (en) * | 2017-02-01 | 2017-10-11 | SanderStrothmann GmbH | Cosmetic skin treatment composition |
Also Published As
Publication number | Publication date |
---|---|
FI842697A0 (en) | 1984-07-04 |
JPS59501986A (en) | 1984-11-29 |
EP0126138A1 (en) | 1984-11-28 |
DK324584A (en) | 1984-07-02 |
DK324584D0 (en) | 1984-07-02 |
ZA838207B (en) | 1984-12-24 |
NO842674L (en) | 1984-07-02 |
FI842697A (en) | 1984-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4518614A (en) | Cosmetic preparation | |
US5153230A (en) | Topical skin cream composition | |
DE69807926T2 (en) | SKIN CARE WITH IMPROVED SKIN HYDRATION | |
EP1002526B1 (en) | Skin whitening composition containing bearberry extract and a reducing agent | |
AU623790B2 (en) | Cosmetic composition | |
US4760096A (en) | Moisturizing skin preparation | |
EP0435483B1 (en) | Cosmetic composition | |
DE68917512T2 (en) | Cosmetic preparation. | |
DE3871974T2 (en) | HAIR PROTECTIVE AGENT AND METHOD. | |
TW568789B (en) | Compositions containing hydroxy acids or retinoids | |
CA2278010A1 (en) | Non-irritating composition for treating acne and other skin conditions | |
WO1984001710A1 (en) | Cosmetic preparation | |
DE69800170T2 (en) | System consisting of phosphonic acid derivatives and metabisulphite to stabilize ascorbic acid | |
US4760095A (en) | Moisturizers | |
US4187291A (en) | Cosmetic composition for the skin | |
DE69205839T2 (en) | Dermatological and cosmetic composition. | |
EP0134954A1 (en) | Sebum secretion accelerator | |
KR102233140B1 (en) | Cosmetic composition for skin improvement containing low molecular weight hyaluronic acid | |
US3694547A (en) | Anti-dandruff hair preparation | |
WO2006122668A1 (en) | Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine | |
DE3029263A1 (en) | Cosmetic cream and liq. compsn. - contg. added de-saccharified, deproteinated, opt. laevo-lactic acid-enriched sour whey serum (AT 15.12.80) | |
JPS62120308A (en) | Cosmetic | |
US6017548A (en) | Skin care composition | |
DE69719200T2 (en) | PREPARATION TO PROTECT THE SKIN AGAINST MECHANICAL IRRITATION | |
US5190758A (en) | Sebaceous excitosecretory agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): AT AU CH DE DK FI GB JP NL NO SE |
|
AL | Designated countries for regional patents |
Designated state(s): AT BE CH DE FR GB LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1983903849 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 842697 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1983903849 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1983903849 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |